viewCellmid Limited

Cellmid CEO and MD Maria Halasz acquires shares in on-market transactions

The company is developing solutions to a range of conditions associated with ageing and inflammatory and autoimmune conditions.

Cellmid Limited - Cellmid CEO and MD Maria Halasz acquires further shares in on-market transaction
Cellmid has operations in Australia, Japan, the USA, Europe and Asia

Cellmid Ltd (ASX:CDY) chief executive officer and MD Maria Halasz has demonstrated her confidence in the company's strategy by acquiring shares in on-market transactions.

Halasz made the purchases totalling more than 152,000 in an indirect interest on June 18 and 22.

She acquired 100,000 shares at 11 cents per share and a further 52,789 shares at 12 cents per share, bringing the total number of shares held in that interest to 2.58 million with another 420,000 held in a direct interest.

Participation in placement

The on-market purchases follow her participation in the company’s placement earlier this year after receiving shareholder approval.

She acquired 227,273 shares at 22 cents per share with a total value of $50,000 in the indirect interest.

Also on June 18, non-executive director Dennis Eck acquired more than 4.318 million shares with a value of $950,000 in the placement.

Quick facts: Cellmid Limited

Price: 0.09 AUD

Market: ASX
Market Cap: $11.45 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...


Cellmid expects to see strong revenue growth out of China ahead of...

Cellmid Ltd’s (ASX:CDY) Maria Halasz speaks to Proactive's Andrew Scott following the news it's received the first order from Ourui Health Management Limited (OHM) for the sale of its Japanese, Ju-Ju® and Lexilis® branded, anti-ageing hair and skincare products in China. The first order of...

on 27/1/21

2 min read